JPMorgan Chase & Co. Issues Pessimistic Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works (NYSE:BBWI – Get Free Report) had its price objective dropped by investment analysts at JPMorgan Chase & Co. from $24.00 to $23.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 22.16% from the stock’s previous close.

Several other equities analysts also recently commented on the stock. UBS Group upped their price target on shares of Bath & Body Works from $17.00 to $22.00 and gave the company a “neutral” rating in a research note on Friday, November 13th. Deutsche Bank set a $22.00 price objective on Bath & Body Works in a research note on Thursday, August 27th. Jefferies Financial Group reiterated a “hold” rating and set a $21.00 price target on shares of Bath & Body Works in a report on Thursday. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price on the stock in a report on Tuesday, August 18th. Finally, Robert W. Baird decreased their target price on shares of Bath & Body Works from $23.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday. Four equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $22.20.

Read Our Latest Report on BBWI

Bath & Body Works Price Performance

BBWI stock traded down $0.08 during midday trading on Friday, hitting $18.83. The company’s stock had a trading volume of 2,793,431 shares, compared to its average volume of 6,028,515. The company’s fifty day moving average price is $19.24 and its 200 day moving average price is $19.77. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $24.94. The stock has a market capitalization of $3.80 billion, a P/E ratio of 4.91, a PEG ratio of 0.93 and a beta of 1.31.

Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.14. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the prior year, the firm earned $0.37 EPS. Bath & Body Works’s quarterly revenue was down 1.1% compared to the same quarter last year. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Equities analysts expect that Bath & Body Works will post 2.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Bath & Body Works during the 2nd quarter valued at about $449,065,000. Marshall Wace LLP raised its stake in shares of Bath & Body Works by 458.9% during the third quarter. Marshall Wace LLP now owns 3,260,323 shares of the company’s stock worth $51,904,000 after acquiring an additional 2,677,026 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in shares of Bath & Body Works by 34.2% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company’s stock worth $51,857,000 after acquiring an additional 707,449 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Bath & Body Works by 885.7% in the 1st quarter. Renaissance Technologies LLC now owns 2,732,733 shares of the company’s stock worth $51,020,000 after acquiring an additional 2,455,500 shares during the last quarter. Finally, Bank of America Corp DE bought a new stake in shares of Bath & Body Works in the 2nd quarter worth approximately $62,249,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works News Roundup

Investors following BBWI have been watching these news items:

  • Positive Sentiment: BBWI announced a new $500 million share-repurchase program and says its Fuel for Growth initiative is expected to generate $200 million in cost savings, potentially supporting earnings and shareholder returns. Long-term investor takeaways
  • Neutral Sentiment: Wells Fargo, Morgan Stanley and Baird each lowered their price targets, but retained their respective Overweight, Equal Weight and Neutral ratings. Their revised targets remain above the recent share price, indicating mixed views rather than a broad downgrade. Wells Fargo rating
  • Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a new seasonal offering, though the financial impact is not yet clear. Pantone collaboration announcement

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

See Also

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.